Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules.

The basic-helix-loop-helix-leucine-zipper domains of the c-Myc oncoprotein and its obligate partner Max are intrinsically disordered (ID) monomers that undergo coupled folding and binding upon heterodimerization. We have identified the binding sites and determined the structural means by which two unrelated small molecules, 10058-F4 and 10074-G5, bind c-Myc and stabilize the ID monomer over the highly ordered c-Myc-Max heterodimer. In solution, the molecules bind to distinct regions of c-Myc and thus limit its ability to interact with Max and assume a more rigid and defined conformation. The identification of multiple, specific binding sites on an ID domain suggests that small molecules may provide a general means for manipulating the structure and function of ID proteins, such as c-Myc.

[1]  H. Dyson,et al.  Coupling of folding and binding for unstructured proteins. , 2002, Current opinion in structural biology.

[2]  John S Lazo,et al.  Improved low molecular weight Myc-Max inhibitors , 2007, Molecular Cancer Therapeutics.

[3]  G. Rose,et al.  A backbone-based theory of protein folding , 2006, Proceedings of the National Academy of Sciences.

[4]  W. Goddard,et al.  UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations , 1992 .

[5]  P. Tompa,et al.  Structural disorder throws new light on moonlighting. , 2005, Trends in biochemical sciences.

[6]  Narasimha Sreerama,et al.  Computation and Analysis of Protein Circular Dichroism Spectra , 2004, Numerical Computer Methods, Part D.

[7]  R. Nussinov,et al.  Extended disordered proteins: targeting function with less scaffold. , 2003, Trends in biochemical sciences.

[8]  P. Tompa.  Intrinsically unstructured proteins. , 2002, Trends in biochemical sciences.

[9]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[10]  R. T. Ross,et al.  Absorption and Fluorescence of Tyrosine Hydrogen-Bonded to Amide-like Ligands , 1998 .

[11]  John S Lazo,et al.  Low molecular weight inhibitors of Myc–Max interaction and function , 2003, Oncogene.

[12]  P. Vogt,et al.  A credit-card library approach for disrupting protein-protein interactions. , 2006, Bioorganic & medicinal chemistry.

[13]  V. Uversky.  Natively unfolded proteins: A point where biology waits for physics , 2002, Protein science : a publication of the Protein Society.

[14]  P. Radivojac,et al.  PROTEINS: Structure, Function, and Bioinformatics Suppl 7:176–182 (2005) Exploiting Heterogeneous Sequence Properties Improves Prediction of Protein Disorder , 2022 .

[15]  Stephen K. Burley,et al.  X-Ray Structures of Myc-Max and Mad-Max Recognizing DNA Molecular Bases of Regulation by Proto-Oncogenic Transcription Factors , 2003, Cell.

[16]  H. Dyson,et al.  Intrinsically unstructured proteins and their functions , 2005, Nature Reviews Molecular Cell Biology.

[17]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[18]  Dirk Eick,et al.  Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules. , 2006, Chemistry & biology.

[19]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[20]  A. Khodair.  A Convenient Synthesis of 2‐Arylidene‐5H‐thiazolo[2,3‐b]quinazoline‐3,5[2H]‐diones and Their Benzoquinazoline Derivatives. , 2003 .

[21]  F. Richards,et al.  The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. , 1992, Biochemistry.

[22]  Atsushi Yoshimori,et al.  Identification of a drug target motif: an anti-tumor drug NK109 interacts with a PNxxxxP. , 2005, Biochemical pharmacology.

[23]  L. Penn,et al.  Cancer therapeutics: targeting the dark side of Myc. , 2005, European journal of cancer.

[24]  T. Kodadek.  Inhibition of proteolysis and other posttranslational modifications with substrate-targeted inhibitors. , 2002, Biopolymers.

[25]  Christopher J. Oldfield,et al.  Intrinsically disordered proteins in human diseases: introducing the D2 concept. , 2008, Annual review of biophysics.

[26]  D. Eliezer,et al.  Folding of the repeat domain of tau upon binding to lipid surfaces. , 2006, Journal of molecular biology.

[27]  D. Boger,et al.  Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Wolfe,et al.  Substrate-targeting γ-secretase modulators , 2008, Nature.

[29]  R. W. Janes,et al.  Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein. , 1999, Journal of molecular biology.

[30]  H. Dyson,et al.  Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. , 1999, Journal of molecular biology.

[31]  Christopher J. Oldfield,et al.  Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling , 2005, Journal of molecular recognition : JMR.

[32]  R. Raines,et al.  Fluorescence polarization assay to quantify protein-protein interactions. , 2004, Methods in molecular biology.

[33]  Marc S. Cortese,et al.  Rational drug design via intrinsically disordered protein. , 2006, Trends in biotechnology.

[34]  Michelle R. Arkin,et al.  Small-molecule inhibitors of protein–protein interactions: progressing towards the dream , 2004, Nature Reviews Drug Discovery.

[35]  L. Iakoucheva,et al.  Intrinsic disorder in cell-signaling and cancer-associated proteins. , 2002, Journal of molecular biology.

[36]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[37]  David S. Wishart,et al.  PREDITOR: a web server for predicting protein torsion angle restraints , 2006, Nucleic Acids Res..

[38]  R. Eisenman,et al.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. , 1991, Science.

[39]  C. Oliveira,et al.  P2-339: Development of a screening platform for the identification of new Rac1/Rac1b inhibitors active in the prevention of amyloid-beta production , 2008, Alzheimer's & Dementia.

[40]  Marc S. Cortese,et al.  Comparing and combining predictors of mostly disordered proteins. , 2005, Biochemistry.

[41]  E. Prochownik,et al.  Distinct Roles for MAX Protein Isoforms in Proliferation and Apoptosis* , 1997, The Journal of Biological Chemistry.

[42]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[43]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[44]  R. Brüschweiler,et al.  Covariance nuclear magnetic resonance spectroscopy. , 2004, The Journal of chemical physics.